• LAST PRICE
    0.0236
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0201/ 100
  • Ask / Lots
    0.0293/ 100
  • Open / Previous Close
    --- / 0.0236
  • Day Range
    ---
  • 52 Week Range
    Low 0.0135
    High 0.0500
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.0229
TimeVolumeAPLIF
09:32 ET20000.0196
11:20 ET1000000.0252
02:20 ET20000.0236
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAPLIF
Appili Therapeutics Inc
4.2M
---
---
As of 2024-11-22

Company Information

Appili Therapeutics Inc. is a Canada-based biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures. The Company is advancing a diverse range of anti-infectives, including ready-made suspension of metronidazole for the treatment of antimicrobial infections, a vaccine candidate to eliminate a serious biological weapon threat, and a topical antiparasitic for the treatment of a disfiguring disease. Its anti-infective product development portfolio includes three programs: LIKMEZ (ATI-1501), ATI-1701 and ATI-1801. LIKMEZ (ATI-1501) is its advanced commercial stage asset, a liquid oral reformulation of the antibiotic metronidazole to treat serious anaerobic and protozoal infections. ATI-1701 is a live-attenuated vaccine for Francisella tularensis (F. tularensis), the bacterium which causes tularemia. ATI-1801 is a topical formulation of paromomycin (15% w/w) under advanced clinical development for the treatment of cutaneous leishmaniasis.

Contact Information

Headquarters
#21-1344 Summer StreetHALIFAX, NS, Canada B3H 0A8
Phone
902-442-4655
Fax
902-442-4655

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.2M
Revenue (TTM)
$494.8K
Shares Outstanding
121.3M
Appili Therapeutics Inc does not pay a dividend.
Beta
0.95
EPS
$-0.03
Book Value
$-0.09
P/E Ratio
---
Price/Sales (TTM)
8.6
Price/Cash Flow (TTM)
---
Operating Margin
-1,985.60%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.